Induction chemotherapy followed by definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma: a randomized phase II trial
The benefit of induction chemotherapy before definitive chemoradiotherapy (CRT) for patients with esophageal cancer is still uncertain. The results of this phase II randomized trial show that the addition of induction chemotherapy to CRT does not improve the response rate or survival of patients wit...
Guardado en:
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/036e46d12f2c46d4b935d155a3a4956f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:036e46d12f2c46d4b935d155a3a4956f |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:036e46d12f2c46d4b935d155a3a4956f2021-12-02T16:10:52ZInduction chemotherapy followed by definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma: a randomized phase II trial10.1038/s41467-021-24288-12041-1723https://doaj.org/article/036e46d12f2c46d4b935d155a3a4956f2021-06-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-24288-1https://doaj.org/toc/2041-1723The benefit of induction chemotherapy before definitive chemoradiotherapy (CRT) for patients with esophageal cancer is still uncertain. The results of this phase II randomized trial show that the addition of induction chemotherapy to CRT does not improve the response rate or survival of patients with unresectable esophageal squamous cell carcinoma.Shiliang LiuLiling LuoLei ZhaoYujia ZhuHui LiuQiaoqiao LiLing CaiYonghong HuBo QiuLi ZhangJingxian ShenYadi YangMengzhong LiuMian XiNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-8 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Shiliang Liu Liling Luo Lei Zhao Yujia Zhu Hui Liu Qiaoqiao Li Ling Cai Yonghong Hu Bo Qiu Li Zhang Jingxian Shen Yadi Yang Mengzhong Liu Mian Xi Induction chemotherapy followed by definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma: a randomized phase II trial |
description |
The benefit of induction chemotherapy before definitive chemoradiotherapy (CRT) for patients with esophageal cancer is still uncertain. The results of this phase II randomized trial show that the addition of induction chemotherapy to CRT does not improve the response rate or survival of patients with unresectable esophageal squamous cell carcinoma. |
format |
article |
author |
Shiliang Liu Liling Luo Lei Zhao Yujia Zhu Hui Liu Qiaoqiao Li Ling Cai Yonghong Hu Bo Qiu Li Zhang Jingxian Shen Yadi Yang Mengzhong Liu Mian Xi |
author_facet |
Shiliang Liu Liling Luo Lei Zhao Yujia Zhu Hui Liu Qiaoqiao Li Ling Cai Yonghong Hu Bo Qiu Li Zhang Jingxian Shen Yadi Yang Mengzhong Liu Mian Xi |
author_sort |
Shiliang Liu |
title |
Induction chemotherapy followed by definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma: a randomized phase II trial |
title_short |
Induction chemotherapy followed by definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma: a randomized phase II trial |
title_full |
Induction chemotherapy followed by definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma: a randomized phase II trial |
title_fullStr |
Induction chemotherapy followed by definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma: a randomized phase II trial |
title_full_unstemmed |
Induction chemotherapy followed by definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma: a randomized phase II trial |
title_sort |
induction chemotherapy followed by definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma: a randomized phase ii trial |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/036e46d12f2c46d4b935d155a3a4956f |
work_keys_str_mv |
AT shiliangliu inductionchemotherapyfollowedbydefinitivechemoradiotherapyversuschemoradiotherapyaloneinesophagealsquamouscellcarcinomaarandomizedphaseiitrial AT lilingluo inductionchemotherapyfollowedbydefinitivechemoradiotherapyversuschemoradiotherapyaloneinesophagealsquamouscellcarcinomaarandomizedphaseiitrial AT leizhao inductionchemotherapyfollowedbydefinitivechemoradiotherapyversuschemoradiotherapyaloneinesophagealsquamouscellcarcinomaarandomizedphaseiitrial AT yujiazhu inductionchemotherapyfollowedbydefinitivechemoradiotherapyversuschemoradiotherapyaloneinesophagealsquamouscellcarcinomaarandomizedphaseiitrial AT huiliu inductionchemotherapyfollowedbydefinitivechemoradiotherapyversuschemoradiotherapyaloneinesophagealsquamouscellcarcinomaarandomizedphaseiitrial AT qiaoqiaoli inductionchemotherapyfollowedbydefinitivechemoradiotherapyversuschemoradiotherapyaloneinesophagealsquamouscellcarcinomaarandomizedphaseiitrial AT lingcai inductionchemotherapyfollowedbydefinitivechemoradiotherapyversuschemoradiotherapyaloneinesophagealsquamouscellcarcinomaarandomizedphaseiitrial AT yonghonghu inductionchemotherapyfollowedbydefinitivechemoradiotherapyversuschemoradiotherapyaloneinesophagealsquamouscellcarcinomaarandomizedphaseiitrial AT boqiu inductionchemotherapyfollowedbydefinitivechemoradiotherapyversuschemoradiotherapyaloneinesophagealsquamouscellcarcinomaarandomizedphaseiitrial AT lizhang inductionchemotherapyfollowedbydefinitivechemoradiotherapyversuschemoradiotherapyaloneinesophagealsquamouscellcarcinomaarandomizedphaseiitrial AT jingxianshen inductionchemotherapyfollowedbydefinitivechemoradiotherapyversuschemoradiotherapyaloneinesophagealsquamouscellcarcinomaarandomizedphaseiitrial AT yadiyang inductionchemotherapyfollowedbydefinitivechemoradiotherapyversuschemoradiotherapyaloneinesophagealsquamouscellcarcinomaarandomizedphaseiitrial AT mengzhongliu inductionchemotherapyfollowedbydefinitivechemoradiotherapyversuschemoradiotherapyaloneinesophagealsquamouscellcarcinomaarandomizedphaseiitrial AT mianxi inductionchemotherapyfollowedbydefinitivechemoradiotherapyversuschemoradiotherapyaloneinesophagealsquamouscellcarcinomaarandomizedphaseiitrial |
_version_ |
1718384390871973888 |